Model-Informed Drug Development (MIDD) consulting services
A quantitative framework to support and inform development program strategies and decisions.
Benefits
Enhance MIDD at every level
At Pharmetheus we have a blend of experience and expertise to enhance MIDD at the program, and or organizational level.
Our consultants are not only technical experts when it comes to Pharmacometrics and PBPK-QSP, they are also excellent strategists when it comes to how to combine a series of different modeling approaches to support a holistic drug development strategy.
Benefits we have seen achieved with utilizing our MIDD solutions include augmented clinical teams with embedded scientists, replaced/reduced/optimized trials with appropriate strategies, and increased visibility of MIDD within the organization through involvement of external experts.
We offer a range of MIDD solutions, including:
- Scientific advice at the analysis, trial, compound, and portfolio levels
- Contribution to and review of R&D programs
- Delivery of a range of MIDD components in a “fit for purpose” manner
- Presentations focused on organizational and team MIDD awareness
- Workshops focused on MIDD implementation
- Workshops focused on MIDD application within a particular therapeutic area or context of use
Our passion
Recommended solutions
The solutions linked to our Platforms aim to continuously seek opportunities to realize the full potential of this paradigm.
Related service
Model-Informed Bioequivalence and Biosimilarity consulting services
Our model-informed strategies reduce development risk, meet evolving regulatory standards, support biowaiver approaches, and offer robust, validated alternatives to traditional non-compartmental analysis (NCA) methods.